Sign in

CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company

CAPRICOR THERAPEUTICS, INC.

Sign in to watch
Ticker
CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(310) 358-3200
Business address
10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
Former names
Nile Therapeutics, Inc., SMI PRODUCTS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 97 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-03-03 Manzo Louis Director Grant or award · Stock Option (right to buy) +15,000 15,000
2015-03-03 GRASMICK LOUIS J Director Grant or award · Stock Option (right to buy) +7,500 7,500
2015-03-03 DUNBAR GEORGE W JR Director Grant or award · Stock Option (right to buy) +7,500 7,500
2015-03-03 Litvack Frank Director Grant or award · Stock Option (right to buy) +250,000 250,000
2015-03-03 Krasney Karen EVP, General Counsel Grant or award · Stock Option (right to buy) +30,000 30,000
2015-03-03 Musket David B Director Grant or award · Stock Option (right to buy) +47,500 47,500
2015-03-03 COLLIER EARL M JR Director Grant or award · Stock Option (right to buy) +7,500 7,500
2013-10-23 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise · Stock Option (Right to Buy) −2,178 0

Page 24 of 24 · 468 trades